Gastroenterology and Liver

Viral Hepatitis Research

Viral hepatitis remains a significant global health challenge, with millions affected by hepatitis B, C, D, and E worldwide. This session will focus on advances in diagnostics, antiviral therapies, and strategies for disease elimination. Participants will learn about molecular and serological testing, novel treatment regimens, and the role of public health interventions in controlling viral spread. Special emphasis will be placed on hepatitis B and C, including screening programs, treatment monitoring, and prevention strategies such as vaccination and education campaigns.

The track also explores emerging research in hepatitis pathogenesis, drug resistance, and novel therapeutics. Participants will engage with clinical trial data, real-world outcomes, and translational research that informs evidence-based care. Policy, global elimination goals, and strategies to overcome healthcare disparities will be discussed to foster collaborative approaches. This session provides an ideal platform for clinicians, researchers, and public health professionals to present research, exchange knowledge, and contribute to the global effort against viral hepatitis.